Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Decon Bio-Sci-Technology is a prominent Chinese biotechnology company specializing in the development and manufacture of high-performance degradable medical materials. Established in 2005 and headquartered in Changzhou, the company focuses on three core areas: absorbable surgical sutures, orthopedic internal fixation systems, and medical aesthetics. Their product portfolio is built upon proprietary technology in synthetic absorbable polymers, including polyglycolic acid (PGA) and poly-L-lactic acid (PLLA). As a key subsidiary of the Dikang Group, Jiangsu Decon has established itself as a leading supplier of absorbable medical devices both in China and internationally. The company maintains advanced GMP-compliant manufacturing facilities and continues to expand its pipeline into regenerative medicine and advanced tissue engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Decon Bio-Sci-Technology.